[HTML][HTML] Safety and efficacy of bridging to lung transplantation with antifibrotic drugs in idiopathic pulmonary fibrosis: a case series
I Delanote, WA Wuyts, J Yserbyt, EK Verbeken… - BMC pulmonary …, 2016 - Springer
Background Following recent approval of pirfenidone and nintedanib for idiopathic
pulmonary fibrosis (IPF), questions arise about the use of these antifibrotics in patients …
pulmonary fibrosis (IPF), questions arise about the use of these antifibrotics in patients …
Safety and efficacy of bridging to lung transplantation with antifibrotic drugs in idiopathic pulmonary fibrosis: a case series.
I Delanote, WA Wuyts, J Yserbyt… - BMC Pulmonary …, 2016 - europepmc.org
Background Following recent approval of pirfenidone and nintedanib for idiopathic
pulmonary fibrosis (IPF), questions arise about the use of these antifibrotics in patients …
pulmonary fibrosis (IPF), questions arise about the use of these antifibrotics in patients …
[PDF][PDF] Safety and efficacy of bridging to lung transplantation with antifibrotic drugs in idiopathic pulmonary fibrosis: a case series
I Delanote, WA Wuyts, J Yserbyt, EK Verbeken… - 2016 - lirias.kuleuven.be
Background: Following recent approval of pirfenidone and nintedanib for idiopathic
pulmonary fibrosis (IPF), questions arise about the use of these antifibrotics in patients …
pulmonary fibrosis (IPF), questions arise about the use of these antifibrotics in patients …
[PDF][PDF] Safety and efficacy of bridging to lung transplantation with antifibrotic drugs in idiopathic pulmonary fibrosis: a case series
I Delanote, WA Wuyts, J Yserbyt, EK Verbeken… - 2016 - cyberleninka.org
Background: Following recent approval of pirfenidone and nintedanib for idiopathic
pulmonary fibrosis (IPF), questions arise about the use of these antifibrotics in patients …
pulmonary fibrosis (IPF), questions arise about the use of these antifibrotics in patients …
[PDF][PDF] Safety and efficacy of bridging to lung transplantation with antifibrotic drugs in idiopathic pulmonary fibrosis: a case series
I Delanote, WA Wuyts, J Yserbyt, EK Verbeken… - 2016 - core.ac.uk
Background: Following recent approval of pirfenidone and nintedanib for idiopathic
pulmonary fibrosis (IPF), questions arise about the use of these antifibrotics in patients …
pulmonary fibrosis (IPF), questions arise about the use of these antifibrotics in patients …
[引用][C] Safety and efficacy of bridging to lung transplantation with antifibrotic drugs in idiopathic pulmonary fibrosis: a case series
I Delanote, WA Wuyts, J Yserbyt, EK Verbeken… - BMC Pulmonary …, 2016 - cir.nii.ac.jp
Safety and efficacy of bridging to lung transplantation with antifibrotic drugs in idiopathic
pulmonary fibrosis: a case series | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …
pulmonary fibrosis: a case series | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …
Safety and efficacy of bridging to lung transplantation with antifibrotic drugs in idiopathic pulmonary fibrosis: a case series
I Delanote, WA Wuyts, J Yserbyt… - BMC pulmonary …, 2016 - pubmed.ncbi.nlm.nih.gov
Background Following recent approval of pirfenidone and nintedanib for idiopathic
pulmonary fibrosis (IPF), questions arise about the use of these antifibrotics in patients …
pulmonary fibrosis (IPF), questions arise about the use of these antifibrotics in patients …
[HTML][HTML] Safety and efficacy of bridging to lung transplantation with antifibrotic drugs in idiopathic pulmonary fibrosis: a case series
I Delanote, WA Wuyts, J Yserbyt… - BMC …, 2016 - bmcpulmmed.biomedcentral.com
Following recent approval of pirfenidone and nintedanib for idiopathic pulmonary fibrosis
(IPF), questions arise about the use of these antifibrotics in patients awaiting lung …
(IPF), questions arise about the use of these antifibrotics in patients awaiting lung …
Safety and efficacy of bridging to lung transplantation with antifibrotic drugs in idiopathic pulmonary fibrosis: a case series
I Delanote, WA Wuyts, J Yserbyt, EK Verbeken… - BMC Pulmonary …, 2016 - go.gale.com
Background Following recent approval of pirfenidone and nintedanib for idiopathic
pulmonary fibrosis (IPF), questions arise about the use of these antifibrotics in patients …
pulmonary fibrosis (IPF), questions arise about the use of these antifibrotics in patients …
Safety and efficacy of bridging to lung transplantation with antifibrotic drugs in idiopathic pulmonary fibrosis: a case series
I Delanote, WA Wuyts, J Yserbyt… - BMC Pulmonary …, 2016 - search.proquest.com
Background Following recent approval of pirfenidone and nintedanib for idiopathic
pulmonary fibrosis (IPF), questions arise about the use of these antifibrotics in patients …
pulmonary fibrosis (IPF), questions arise about the use of these antifibrotics in patients …